Synonym
FPL 63547; Utibapril; 109683-61-6; Utibaprilo; Utibaprilum; Utibapril [INN:BAN]
IUPAC/Chemical Name
5-(tert-butyl)-3-((1-ethoxy-1-oxo-4-phenylbutan-2-yl)alanyl)-2,3-dihydro-1,3,4-thiadiazole-2-carboxylic acid
InChi Key
FTYVYAGWBXTWTN-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H31N3O5S/c1-6-30-20(29)16(13-12-15-10-8-7-9-11-15)23-14(2)17(26)25-18(19(27)28)31-21(24-25)22(3,4)5/h7-11,14,16,18,23H,6,12-13H2,1-5H3,(H,27,28)
SMILES Code
CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(SC(=N2)C(C)(C)C)C(=O)O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
449.57
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Buikema H, Pinto YM, van Geel PP, Rooks G, de Langen CD, de Graeff PA, van
Gilst WH. Differential inhibition of plasma versus tissue ACE by utibapril:
biochemical and functional evidence for inhibition of vascular ACE activity. J
Cardiovasc Pharmacol. 1997 May;29(5):684-91. doi:
10.1097/00005344-199705000-00018. PMID: 9213213.
2: Carr RD, Higgs L, Killingback PG, Nicol AK, O'Connor SE, Robson A, Wells E,
Simpson WT. Pharmacological properties of FPL 63547, a novel inhibitor of
angiotensin-converting enzyme. Br J Pharmacol. 1990 May;100(1):83-9. doi:
10.1111/j.1476-5381.1990.tb12056.x. PMID: 2164863; PMCID: PMC1917465.
3: Carr RD, Cooper AE, Hutchinson R, Mann J, O'Connor SE, Robinson DH, Wells E.
Preferential biliary elimination of FPL 63547, a novel inhibitor of angiotensin-
converting enzyme, in the rat. Br J Pharmacol. 1990 May;100(1):90-4. doi:
10.1111/j.1476-5381.1990.tb12057.x. PMID: 2164864; PMCID: PMC1917479.